José has been practicing law since 2000 with a focus on corporate transactions, healthcare, and venture capital.
In corporate transactions, his practice focuses on corporate formation, venture capital financings, mergers & acquisitions, strategic corporate transactions, and general advisory regarding corporate and financing strategy.
He has expertise, as well, with healthcare transactions and regulations, including HIPAA, Stark, and Anti-Kickback Statute regulatory advice. José previously worked as general counsel for a physician-owned healthcare system and at a national healthcare company focusing on post-acute care and eldercare.
As assistant general counsel for an international Australian-based gaming company in Las Vegas, he handled international customer contracts, as well as managed international acquisitions of software companies.
He teaches health law for NYU’s Masters of Public Health program, and previously taught a corporate transactions course at UNLV’s law school.
He loves to travel, having visited over 60 countries and speaks several foreign languages: Spanish, Italian, French, and Russian.
José uses his broad experience to provide efficient and effective representation for his clients.
EDUCATION BACKGROUND
J.D. – University of Pennsylvania Law School 2000
A.B., cum laude – Harvard College – 1997
HONORS AND AWARDS
D.C. Bar’s Frederick B. Abramson Award for co-authoring “Independent Directors and Tax Exempt Organizations”
PROFESSIONAL AFFILIATIONS
State Bar of Texas: Business Law; and Corporate Counsel Sections
Mentor, Venturewell’s ASPIRE startup accelerator program
Global Mentor, WeWork Labs startup accelerator program
BAR ADMISSIONS
Texas State Bar
PUBLICATIONS AND PRESENTATIONS
“What’s Wrong with a Washout: Fiduciary Duties of a Venture Capitalist Investor in a Washout Financing,” Houston Business and Tax Law Journal
“Anti-Dilution Provisions: Which One is Best for Founders?”, Startups San Antonio
REPRESENTATIVE EXPERIENCE
Since 2019, represented investor or issuer in more than 40 venture capital financings with over $200 million invested
Represented investor in $15 million Series A financing
Represented health tech company in a private offering of convertible notes
Represented investor in CPG company’s $20 million Series B preferred stock financing
Represented investor in secondary purchase of $6 million of Series A preferred stock
Represented seller in the sale of a chain of urgent care centers
Represented buyer in the purchase of a medical practice
Represented developer in the development of an ambulatory surgery center
Represented buyer in international purchase of a software development company
